Flex Subsidiary Nextracker Prices Equity Offering

Nextracker Inc (NASDAQ: NXT) has 

Nextracker Inc (NASDAQ:NXT) has priced its underwritten offering of 14.2 million shares by company and 2.3 million shares by certain stockholders at $36.50 per share.

The offer price represents a 2% discount to the company’s closing price on June 28.

In addition, the underwriters of the offering have been granted a 30-day option to purchase up to 1.65 million additional shares at the offering price.

Nextracker expects to use all of the net proceeds from its offering of 14.2 million shares to purchase an equivalent amount of Nextracker LLC common units from Yuma Inc, an indirect wholly-owned subsidiary of Flex Ltd., and TPG Rise Flash L.P, an affiliate of the global alternative asset management firm TPG Inc (NASDAQ: TPG).

The company will not receive any proceeds from the sale of the shares of the selling stockholders.

The offering is expected to close on July 3, 2023.

Price Action: NXT shares closed lower by 1.25% at $37.13 on Wednesday.

Total
0
Shares
Related Posts
Read More

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products for the Brazilian medical cannabis market. MediPharm has already received GMP certifications from the US FDA, the European Union, and Australia's TGA, and holds a drug establishment license from Health Canada. The Brazilian medical cannabis market is projected to reach CAD380m (USD282m) by 2025, according to industry forecasts. MediPharm Labs, which already produces two medical cannabis products with full ANVISA authorization for the Brazilian market, is potentially set for further product authorizations through the regulatory body, according to reports.

MEDIF